ECSP993101A - METHOD FOR THE TREATMENT OF NEOVASCULAR EYE DISEASES - Google Patents

METHOD FOR THE TREATMENT OF NEOVASCULAR EYE DISEASES

Info

Publication number
ECSP993101A
ECSP993101A ECSP993101A ECSP993101A EC SP993101 A ECSP993101 A EC SP993101A EC SP993101 A ECSP993101 A EC SP993101A EC SP993101 A ECSP993101 A EC SP993101A
Authority
EC
Ecuador
Prior art keywords
treatment
eye diseases
neovascular eye
neovascular
diseases
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Jeannette Marjorie Wood
Romulus Kimbro Brazzell
Peter Anthony Campochiaro
Frances Elizabeth Kane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993101 priority Critical patent/ECSP993101A/en
Publication of ECSP993101A publication Critical patent/ECSP993101A/en

Links

Abstract

La invención se refiere al uso de ciertas ftalazinas en la preparación de medicamentos para el tratamiento de nevascularización ocular.The invention relates to the use of certain phthalazines in the preparation of medicaments for the treatment of ocular nevascularization.

ECSP993101 1999-08-13 1999-08-13 METHOD FOR THE TREATMENT OF NEOVASCULAR EYE DISEASES ECSP993101A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993101 ECSP993101A (en) 1999-08-13 1999-08-13 METHOD FOR THE TREATMENT OF NEOVASCULAR EYE DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993101 ECSP993101A (en) 1999-08-13 1999-08-13 METHOD FOR THE TREATMENT OF NEOVASCULAR EYE DISEASES

Publications (1)

Publication Number Publication Date
ECSP993101A true ECSP993101A (en) 1999-10-29

Family

ID=42044088

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993101 ECSP993101A (en) 1999-08-13 1999-08-13 METHOD FOR THE TREATMENT OF NEOVASCULAR EYE DISEASES

Country Status (1)

Country Link
EC (1) ECSP993101A (en)

Similar Documents

Publication Publication Date Title
BR0213358A (en) Flibanserin use
CO4340688A1 (en) QUINAZOLINE DERIVATIVES AND PROCEDURES FOR THE USE OF THE SAME, AS AGENTS AGAINST CANCER, IN MAMMALS.
IS7215A (en) Methods for the treatment of ocular diseases of the eye
BR0210855A (en) Method of Manufacturing Extended Release Formulations
BR0309875A (en) methods and compositions for treating peripheral nervous system disorders and novel compounds useful therefor
BRPI0407662B8 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
BR0314354A (en) Formation for lipophilic people
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
DE60239931D1 (en) COMBINATION THERAPY
TR200002218T2 (en) 2- (Purin-9-yl) -Tetrahydrofuran -3,4-Diol derivatives
CY1108610T1 (en) IL-2 Peptides and their derivatives and their use as therapeutic agents
AR034213A1 (en) COMPOSITIONS OF DRUGS ON THE BASE OF ANTI-POLINERGIC AGENTS AND INHIBITORS OF PDE-IV
BR9814923A (en) Method for treating alzheimer's disease
DE60033649D1 (en) COMPOUNDS AND THERAPEUTIC METHODS
HUP0400548A2 (en) Use of combinations of iop-reducing active inoredient for preparation of pharmaceutical compositions available for treatment glaucoma
BR0213684A (en) Use of Endothelin Receptor Antagonists for the Treatment of Tumor Diseases
MXPA03009273A (en) Agent for topical ophthalmic treatment of ocular inflammatory diseases.
BRPI0407693A (en) use of steroids for the preparation of formulations usable for the treatment of people suffering from eye disorders, as well as the formulation thus obtained
WO2002067971A3 (en) Use of endostatin in the treatment of ocular neovascularization
ES2191449T3 (en) DERIVATIVES OF CICLOPENTABENZOFURANO AND ITS USE.
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
BR0009211A (en) Resorcinol derivatives
CY1106409T1 (en) QUINOLINE DERIVATIVES
WO2000009098A3 (en) Method for treating ocular neovascular diseases
PT1231915E (en) USE OF PLEUROMUTILINE DERIVATIVES FOR TRANSDERMAL TREATMENT OF BACTERIAL DISEASES